CAD, ACS, and ADHF Notes

Coronary Artery Disease (CAD), Acute Coronary Syndrome (ACS), & Acute Decompensated Heart Failure (ADHF)

Objectives

  • Explain the clinical manifestations, complications, diagnostic studies, and collaborative care of the patient with ACS, CAD, and ADHF.

  • Evaluate commonly used drug therapy in treating patients with ACS, CAD, and ADHF.

  • Prioritize key components to include in client education and nursing care of patients recovering from ACS and coronary revascularization procedures.

Cardiovascular Disease (CVD)

  • Leading cause of death in the world.

    • Pt usually comes in due to crisis (ex. MI, hypertension)

  • CVD includes several disorders of the heart and blood vessels.

  • Coronary Artery Disease (CAD): asymptomatic or chronic stable angina (chest pain).

  • Acute Coronary Syndrome (ACS): unstable angina (UA) or myocardial infarction (MI).

  • Perfusion depends on cardiac output (CO).

Coronary Artery Disease (CAD) Review

Coronary Artery Disease

  • A type of blood vessel disorder.

    • Elevations in blood pressure because of plaque building up in arteries

  • C-reactive protein (CRP) may be increased.

    • Inflammatory marker

  • Atherosclerosis: begins as soft deposits of fat that harden with age.

    • CRP also an inflammatory marker

  • Lipid deposits within the innermost layer of the arterial wall (intima).

  • Endothelial injury and inflammation affect the development of atherosclerosis.

  • Damage to the endothelial lining due to: tobacco use, hyperlipidemia, hypertension, toxins, diabetes, inflammation, and infection.

  • Due to high lipoprotein and homocysteine levels.

  • Damage the inner lining of blood vessels.

  • Promote plaque buildup.

  • Change clotting mechanism = clots more likely to occur.

Developmental Stages of Atherosclerosis

  • Fatty Streak (Stage 1):

    • Lipid-filled smooth muscle cells.

    • Yellow tinge appears, appears by age 20.

    • Treatments that lower LDL cholesterol may slow this process.

  • Fibrous Plaque (Stage 2):

    • Progressive changes to endothelium.

    • Grayish/whitish appearance, appears by age 30 and increases with age.

    • Plaques can form on one side of the artery or in a circular fashion.

  • Complicated Lesion (Stage 3):

    • Continued inflammation can result in plaque instability, ulceration, and rupture.

    • Platelets accumulate = thrombus = ↑ GP Iib/IIIa receptors to bind fibrinogen = enlarging thrombus.

    • Most dangerous stage and can lead to ACS.

Collateral Circulation

  • Arterial anastomoses or connections exist within the coronary circulation (creates new pathways)

    • More common in older population as they’ve had more time to develop. An MI is more deadly in younger populations as they’ve had don’t have collateral circulation.

    • Ex. Think of a freeway that’s backed up → people go to the streets.

  • Two Contributing Factors:

    • Angiogenesis: inherited predisposition to develop new blood vessels.

    • Presence of chronic ischemia (poor blood flow).

  • Collateral Circulation has a chance to develop if blockage occurs slowly over a long time.

  • Acute coronary occlusion = not enough time for collateral circulation to develop.

Risk Factors for CAD

  • Non-Modifiable:

    • Age

    • Gender

    • Ethnicity

    • Family History

    • Genetics

  • Major Modifiable:

    • High serum lipids

    • Hypertension

    • Tobacco Use

    • Physical Inactivity

    • Obesity

    • Diabetes

    • Metabolic Syndrome

  • Contributing Modifiable:

    • Psychological state

    • Substance use

Interprofessional and Nursing Management: CAD

  • Identify High-Risk Persons.

    • Obesity

    • Family Hx

    • Diabetes

    • Poor socioeconomic status (unhealthy diet)

    • Sedentary lifestyle

  • Physical Activity.

    • At least 150 minutes of moderate intensity exercise every week.

    • 30 mins of brisk walking per day??

  • Nutrition Therapy.

    • Increase 9:03***LISTEN TO LECTURE

  • Lipid-Lowering Drug Therapy.

  • Complete lipid profile every 5 years beginning age 20; Middle-aged adults every 1-2 years.

  • Antiplatelet Therapy.

  • ↑ Lipoprotein Removal

    • Bile Acid Sequestrants

    • Proprotein Convertase Subtilisin/kexin 9 inhibitors

  • ↓ Cholesterol Absorption

    • Ezetimibe (Zetia)

  • Restrict Lipoprotein Production

    • HMG-CoA reductase inhibitors (Statins)

    • Niacin (water-soluble B vitamin)

    • Fibric Acid Derivatives (Gemfibrozil)

    • ATP-citrate lyase Inhibitor (Bempedoic Acid)

Angina

  • Chest pain due to myocardial ischemia. Artery >70% stenosed or >50% in L main coronary artery.

  • Chronic Stable Angina: due to chronic CAD over a long period of time.

    • Provoked by physical exertion, stress, emotional upset, sexual activity, stimulants.

    • Pain usually lasts for only a few minutes and does not change with position or breathing.

    • Treatment: rest, calming down, sublingual nitroglycerin, drug therapy, ↓ O2 demand & ↑ O2 supply.

  • Unstable Angina: new-onset pain that may increase in frequency, duration, or severity.

    • Occurs at rest or with exertion and lasts more than 10 minutes.

    • Unpredictable.

    • Incomplete occupation of vessel

    • Rupture of unstable plaque = thrombus formation = MI

  • Silent Angina: ischemia with the absence of any symptoms.

    • Diabetes due to neuropathy affecting the nerves that innervate the cardiovascular system.

    • Women: fatigue, SOB, epigastric pain, anxiety, nausea.

Interprofessional and Nursing Care: Angina

  • Drug Therapy: Nitrates (every 5 mins), ACE inhibitors, ARBs, β-adrenergic blockers, Calcium Channel blockers, Lipid-lowering drugs.

  • Goal: ↓ O2 demand & ↑ O2 supply to heart and rest of body.

  • Nursing Care:

    • Pain relief (morphine helps with pulmonary congestion)

    • Immediate and appropriate treatment

    • Preservation of heart muscle if MI suspected

      • Oxygenate (perfuse the issue to prevent cell and muscle death)

    • Effective coping with illness-associated anxiety

    • Participation in a rehabilitation plan

    • Reduction of risk factors

  • Patient Education

    • Identify risk factors for CAD

    • Reduce modifiable risk factors

    • Precipitating factors for angina

    • Medications

    • Diet

    • Physical Exercise

Acute Coronary Syndrome (ACS)

Acute Coronary Syndrome (ACS) - Medical Emergency !!

  • Chest pain from ischemia is prolonged and not immediately reversible

  • Coronary artery disease

  • Chronic stable angina

  • Acute coronary syndrome

    • Unstable angina

    • Non-ST-segment-elevation MI

    • ST-segment-elevation MI (STEMI)

Acute Coronary Syndrome (ACS) - UA

  • Unstable Angina (UA): chest pain at rest, new onset, worsening symptoms, unpredictable, usually lasts >10 mins

  • Chronic angina/CAD that can lead to myocardial infarction

  • Rupture of unstable plaque = thrombus formation

  • Incomplete occlusion of vessel

Acute Coronary Syndrome (ACS) - MI

  • Myocardial Infarction: abrupt stoppage of blood flow through a coronary artery with thrombus d/t platelet aggregation

    • Will have ischemia

    • Pt will present with cold and clammy skin that has a gray-ish in appearance

  • Non-ST-elevation Myocardial Infarction (NSTEMI)

    • Incomplete occlusion of vessel

    • NOT emergent. Cardiac cath in 12-72 hrs. No thrombolytics.

  • ST-elevation Myocardial Infarction (STEMI)

    • Complete occlusion of vessel

    • Emergency - Door to balloon < 90 mins or Door to drug < 30 mins

Clinical Manifestations

  • Chest pain

    • Heavy, pressure, tight, burning, constricted, or crushing pain in the substernal or epigastric area. May radiate to neck, lower jaw, arms, or back.

    • Atypical: “discomfort”, weakness, nausea, indigestion, SOB, fatigue

    • Older adult: mental status change, SOB, pulmonary edema, dizziness, dysrhythmia

  • Sympathetic Nervous System Stimulation

    • ↑ HR and BP initially, vasoconstriction of peripheral blood vessels, diaphoresis, clammy/ashen/cool to touch skin

      • Due to catecholamine release (epinephrine and norepinephrine release as compensation)***

  • Cardiovascular

    • ↓ HR and BP d/t ↓ cardiac output = ↓ renal perfusion & urine output

    • LV dysfunction = Crackles, S3 and S4 heart sounds

    • RV dysfunction = JVD, hepatic engorgement, peripheral edema

  • Nausea and Vomiting

    • LISTEN TO LECTURE 20:17****

  • Fever

Healing Process - MI

  • Cell death = inflammatory process

  • Within 24 hours leukocytes infiltrate the area, dead heart cells release enzymes, lipolysis, and glycogenolysis occurs

  • Necrotic muscle wall thins by day 4 d/t neutrophils and macrophages

  • New scar tissue forming, but still weak after 10-14 days

  • 6 weeks after MI, scar tissue has replaced necrotic tissue → Considered healed at this point.

    • Ø Risk for life-threatening dysrhythmias = sudden cardiac death (SCD)

    • Ø Ventricular remodeling: myocardium hypertrophies and dilates → NOT GOOD.

      • The healthy heart tissue that remains has to compensate for the ischemic muscles.

      • Thick heart muscles cannot pump out blood effectively (hypertrophy) → HF

      • Dilated/thin heart muscles cannot pump to blood effectively → HF

        • Harder force of contraction (increased inotrope)

Diagnostics and Intervention Studies

  • 12 Lead ECG -NOT TESTED ON EACH LEAD

    • Each lead looks at heart at a different angle.

      • Provides information on which coronary artery is involved

      • ST depression and/or T wave inversion facing ischemia/infarction

      • Ischemic changes seen in UA or NSTEMI

      • STEMI

        • ST elevation in the leads facing the infarcted wall

        • ST segment elevation of 1mm or greater in 2 contiguous leads or 2mm or more in V2 and V3

      • Pathologic Q waves → tells us if there’s some type of damage to heart (ex. CMP, late HF)

        • If the patient does not seek immediate treatment

        • Deep Q wave or Q wave ≥ 1/3 of R wave height

      • Always compare to previous ECGs if possible!

Diagnostics and Intervention Studies

Diagnostics and Intervention Studies (Tested on textbook values)

  • Serum Cardiac Biomarkers:

    • UA: negative

    • NSTEMI: positive

Enzyme

Rises In

Peaks In

Remains Elevated For

CK-MB

Normal range: 0 to 4-6% of total CK > 6% positive

6 hrs

18 hrs

24 – 36 hours

Cardiac Troponin I (Most Common)

Negative: < 0.5 ng/mL Indeterminate: 0.5 – 2.3 ng/mL Positive: > 2.3 ng/mL

4 - 6 hrs

10 - 24 hours

10 to 14 days

  • Echocardiogram:

    • Hypokinesis: worsening myocardial contractility

    • Akinesis: absent myocardial contractility

Diagnostics and Intervention Studies

  • Cardiac Catheterization: Gold standard test for increasing angina symptoms to identify and localize CAD and for MI

    • A catheter is inserted into the coronary arteries to do several tests

      • Visual blockages (diagnostic)

      • Open blockages (interventional)

  • Coronary Angiogram/Angiography (CTA):

    • Inject contrast dye to assess blood flow

Interprofessional Care

  • Coronary Revascularization with Percutaneous Coronary Intervention (PCI)

    • Balloon Angioplasty/Intracoronary Stents:

      • Catheter with a deflated balloon tip is inserted into the blocked artery and then inflated. This pushes the plaque against the artery wall and a stent is usually placed. (Insertions site often the groin).

      • Bare metal stent (BMS)

      • Drug-eluting stent (DEC): coated with a drug to reduce overgrowth of the intimal lining

      • DAPT (aspirin + clopidogrel) used until intimal lining grows over stent. Minimum of 12 months. Aspirin continues forever with a stent.

Interprofessional Care

  • Coronary Revascularization with Coronary Artery Bypass Graft Surgery (CABG)

    • Place one or more arterial/venous grafts to provide blood distal to blocked coronary artery. Uses saphenous vein, radial artery, or internal mammary artery.

    • Recommended if patient:

      • Does not respond well to medical management

      • Left main coronary artery or 3-vessel disease

      • Not candidates for PCI

      • Continue to have chest pain after PCI

      • Patients with DM, LV dysfunction, and/or CKD

Interprofessional Care

  • Thrombolytic Therapy (tenecteplase, alteplase)

    • STEMI cases in agencies without cath lab

    • Limits infarction size by dissolving thrombus in the coronary artery

    • Administer within 3o mins

    • Inclusion criteria:

      • Chest pain < 12 hrs with 12-lead ECG findings of a STEMI

      • No absolute contraindications (active internal bleeding, hx of intracranial hemorrhage, etc.)

  • Drug Therapy

    • ACS = Antiplatelet, IV nitro, high-dose atorvastatin

    • Morphine, β-adrenergic blockers, ACE inhibitors/ARBs, antidysrhythmics, lipid-lowering, aldosterone antagonists, stool softeners

  • Nutrition Therapy

    • NPO until stable

Nursing Management

  • Immediate goals: pain relief, quick and appropriate treatment, and preservation of heart muscle

  • Monitor vital signs, continuous ECG monitoring, 12-lead ECG, and draw serum cardiac biomarkers, bed rest/limit activity for 12-24 hours, administer nitro, morphine and oxygen therapy for chest pain, notify HCP of ANY changes (neuro status, etc), emotional support, patient education

    • Heparin—UA and NSTEMI

    • DAPT—NSTEMI and UA with stent

    • Aspirin—UA

    • Cardiac Catheterization—UA and NSTEMI

    • Medical management: PCI or CABG

    • Reperfusion therapy—STEMI

      • Emergent PCI

      • Thrombolytic therapy

  • Physical Activity: MET, limit isometric activities and continue isotonic activities, monitor HR

  • Cardiac Rehabilitation: restoration of a person to an optimal state of function in 6 areas.

  • Sexual Activity: resume when able to tolerate exercise ≥3-5 w/o chest pain or SOB

Nursing Management

  • Pre-procedure: assess allergies, baseline assessment and vitals, NPO 6-12 hours, lab values, patient education

  • Cardiac Catheterization and PCI:

    • Post-procedure: assessment, monitor ECG, administer medications, monitor for complications, patient education

  • CABG:

    • Post-procedure: ICU (24-48 hours), hemodynamic monitoring, arterial line, chest tubes, ECG monitoring, ET tube to vent, urinary catheter, NG tube. Assess fluid status, replace blood/electrolytes, restore temperature, medications, sensory/motor function, pain management

Complications

  • Dysrhythmias: Ventricular tachycardia (VT), Ventricular fibrillation (VF), Heart Blocks

  • Heart Failure: Ventricle’s pumping action is reduced

  • Cardiogenic Shock: occurs when O_2 and nutrients to the tissues are inadequate

    • Goal: ↑ O2 delivery, ↓ O2 demand, and prevent complications

  • Papillary Muscle Dysfunction/Rupture: occurs if infarct near muscle that attaches to the mitral valve

    • New systolic murmur = indication of mitral valve regurgitation

  • Left Ventricular Aneurysm: infarcted heart muscle wall thins and bulges out during contraction

  • Ventricular Septal Wall Rupture/ Left Ventricular Free Wall Rupture: new loud systolic murmur

  • Pericarditis: inflammation of the visceral and/or parietal pericardium

  • Dressler Syndrome: pericarditis and fever 1-8 weeks after MI

Sudden Cardiac Death

  • Sudden Cardiac Death (SCD): abrupt, unexpected death resulting from a variety of cardiac issues without 1 hour of symptom onset

  • Most common cause is acute ventricular dysrhythmias (VT or VF) with or without MI = loss of CO and cerebral blood flow

  • Have a history of LV dysfunction (EF <35%), and/or structural heart disease (hypertrophic cardiomyopathy)

  • Clinical Manifestations: angina, palpitations, dizziness/lightheadedness

  • Use of an implantable cardioverter-defibrillator (ICD) to prevent event

  • Rapid CPR, defibrillation, and use of an automatic external defibrillator (AED) for witnessed arrest cases

Acute Decompensated Heart Failure

Heart Failure Brief Overview

  • Inability to provide sufficient blood to meet the oxygen demands of tissues and organs

  • Primarily caused by HTN and CAD

  • Left-sided HF

    • HFrEF

    • HFpEF

  • Right-sided HF

  • Biventricular

Preload and Afterload Brief Review

  • Preload

    • Used to assess systemic fluid status of patient

    • Indirect estimate of left atrial pressure (LAP)

    • Right Heart Preload:

      • CVP

      • Normal: 2 – 8 mmHg

    • Left Heart Preload:

      • PAWP (LAP)

      • Normal: 6 – 12 mmHg

  • Afterload

    • Right Ventricle Afterload is PVR.

      • Normal PVR: < 250 dynes-sec/cm^5

    • Left Ventricle Afterload is SVR.

      • Normal SVR: 800 – 1200 dynes- sec/cm^5

Summary of Effects of Preload & Afterload on Ventricular Function

  • Increased Preload

    • Stroke Volume

    • Ventricular Work

    • Myocardial O_2 Needs

  • Decreased Preload

    • Stroke Volume

    • Ventricular Work

    • Myocardial O_2 Needs

  • Increased Afterload

    • Ventricular Work

    • Myocardial O_2 Needs

    • Stroke Volume

  • Decreased Afterload

    • Ventricular Work

    • Myocardial O_2 Needs

    • Stroke Volume

Contractility

  • The force & velocity with which ventricular ejection occurs is reflected by the stroke work index (SWI)

  • SWI is the amount of work the ventricle performs with each heartbeat

  • Right Heart Contractility is RVSWI (Right Ventricular Stroke Work Index)

    • Normal 7 – 12 g/m^2/beat

  • Left Heart Contractility is LVSWI (Left Ventricular Stroke Work Index)

    • Normal 40 – 80 g/m^2$$/beat

New York Heart Association Classifications of Heart Failure

  • I – No limitation of activity. Ordinary physical activity does not cause symptoms of HF

  • II – Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of HF

  • III – Marked limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in symptoms of HF.

  • IV – Inability to carry out any physical activity without discomfort. Symptoms may be present at rest.

ADHF Clinical Manifestations

  • Sudden increase in symptoms of HF with a decrease in functional status.

  • Pulmonary congestion

  • Volume overload

  • Interstital edema

  • Tachypnea

  • Pulmonary edema

No

Yes

No

Dry-Warm

Wet-Warm

PAWP normal CO normal

PAWP ↑ CO normal Dyspnea, edema, orthopnea

Signs and Symptoms: none

Yes

Dry-Cold

Wet-Cold

PAWP ↓ or normal CO ↓

PAWP ↑ CO ↓ AMS, ↓ O2 sat, ↓UO, shock

Edema, hypotension, cool extremities

ADHF: Interprofessional Care

  • History and Physical Assessment

    • Determine underlying cause

  • Chest X-Ray

  • 12 lead ECG

  • Hemodynamic Monitoring

  • Echocardiogram

  • Endomyocardial biopsy in certain patients

  • Nuclear Studies

  • Cardiac Cath

  • Labwork

    • Serum chemistry

    • Cardiac Biomarkers

    • BNP / NT-proBNP

    • LFTs

    • Renal Function

    • Thyroid function

    • CBC

    • Lipid profile

    • UA

ADHF: Medications

  • Positive Inotropes:

    • Dopamine

    • Dobutamine

  • PDE inhibitors:

    • Milrinone

  • Vasodilators:

    • Nitroprusside

ADHF: Nursing Management

  • Positioning – High Fowler’s

  • NIPPV or intubation

  • Circulatory Assist Devices – IABP, ECMO, LVAD

  • Continuous vital sign monitoring

  • Urine output

    • Perfusion assessment (I&Os)

  • Continuous ECG

  • Hemodynamic monitoring – BP, PAWP, CO

  • Cardioversion

  • Ultrafiltration